Semaglutide is a long-acting GLP-1 receptor agonist that mimics the action of endogenous glucagon-like peptide-1, an incretin hormone released from the gut in response to food intake
[1] [2] Warning signs include reduced urine output, swelling of ankles or feet, confusion, or nausea
Phase 2 trial data covering 48 weeks shows a safety profile comparable to other approved incretin-based therapies
Among the many stem cell transplantation strategies, stem cell-derived dopamine (SC-DA) neuron transplantation is considered the most promising for treating PD, as it involves transplanting DA neurons into the SNpc to replace lost neurons and restore DA neurotransmission in PD patients (Sonntag et al., 2018
Nerve repair: B12 helps maintain the myelin sheath around your nerves
If insurance adjusters are hinting that your weight is the real issue, your case needs to be approached strategically